Evidence map›Paper›PMID 39655434›Full record

ArticleDevelopment (Cambridge, England)2024

A timed epigenetic switch balances T and ILC lineage proportions in the thymus.

Nicholas A Pease, Kathryn M Denecke, Lihua Chen, Peter Habib Gerges, Hao Yuan Kueh

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Frontiers in immunology · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicholas A PeaseDepartment of Bioengineering, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0001-6140-1949
Kathryn M DeneckeDepartment of Bioengineering, University of Washington, Seattle, WA 98105, USA.
Lihua ChenDepartment of Bioengineering, University of Washington, Seattle, WA 98105, USA.
Peter Habib GergesDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Hao Yuan KuehDepartment of Bioengineering, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0001-6272-6673

Funding

TRAINING IN MOLECULAR BIOPHYSICST32GM008268 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M, ZHENG, NING · 1988 to 2023
$8.6M
A chromatin-based timer controlling T-cell developmentR01HL146478 · NHLBI · UNIVERSITY OF WASHINGTON · PI KUEH, HAO YUAN · 2020 to 2024
$1.9M
Molecular Biophysics Training ProgramT32GM153507 · NIGMS · UNIVERSITY OF WASHINGTON · PI Charles L Asbury, Justin M Kollman · 2024 to 2026
$1.7M
Single-cell analysis of immune cell fate decision makingR00HL119638 · NHLBI · UNIVERSITY OF WASHINGTON · PI KUEH, HAO YUAN · 2016 to 2018
$747k
Regulation of hematopoiesis by epigenetic timing controlF31HL151090 · NHLBI · UNIVERSITY OF WASHINGTON · PI PEASE, NICHOLAS · 2020 to 2020
$38k
John H. Tietze Foundation TrustNational Science Foundation URoL EF-2021552NHLBI NIH HHS F31 HL151090NHLBI NIH HHS R00 HL119638NHLBI NIH HHS R01 HL146478NHLBI NIH HHS R01HL146478NIGMS NIH HHS T32 GM008268NIGMS NIH HHS T32 GM153507NIH HHS R00HL119638University of Washington
6 · The paper itself

Abstract

How multipotent progenitors give rise to multiple cell types in defined numbers is a central question in developmental biology. Epigenetic switches, acting at single gene loci, can generate extended delays in the activation of lineage-specifying genes and impact lineage decisions and cell type output. Here, we analyzed a timed epigenetic switch controlling expression of mouse Bcl11b, a transcription factor that drives T-cell commitment, but only after a multi-day delay. To investigate roles for this delay in controlling lineage decision making, we analyzed progenitors with a deletion in a distal Bcl11b enhancer, which extends this delay by ∼3 days. Strikingly, delaying Bcl11b activation reduces T-cell output but enhances innate lymphoid cell (ILC) generation in the thymus by redirecting uncommitted progenitors to the ILC lineages. Mechanistically, delaying Bcl11b activation promoted ILC redirection by enabling upregulation of the ILC-specifying transcription factor PLZF. Despite the upregulation of PLZF, committed ILC progenitors could subsequently express Bcl11b, which is also needed for type 2 ILC differentiation. These results show that epigenetic switches can control the activation timing and order of lineage-specifying genes to modulate cell type numbers and proportions.

Indexed as

Cell LineageEpigenesis, GeneticRepressor ProteinsThymus GlandT-LymphocytesAnimalsCell DifferentiationLymphocytesMiceMice, Inbred C57BLPromyelocytic Leukemia Zinc Finger ProteinTumor Suppressor ProteinsBcl11b protein, mousePromyelocytic Leukemia Zinc Finger ProteinRepressor ProteinsTumor Suppressor ProteinsZbtb16 protein, mouseBcl11bDevelopmental timingEpigenetic switchesGene regulatory networksInnate lymphoid cellsMousePLZFT cells

Identifiers

PMID39655434
PMCPMC11664168

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.